Artificial intelligence is becoming increasingly integrated into neurological care, particularly in medical imaging, clinical decision support, disease monitoring, and precision medicine. The growing prevalence of neurological disorders and the need to identify conditions earlier are accelerating demand for AI-enabled solutions across hospitals, clinics, and diagnostic settings.

The global AI in neurology market was valued at USD 760.0 million in 2025. It is expected to reach USD 937.2 million in 2026 and is projected to expand to USD 4,451.5 million by 2033, registering a 24.9% CAGR from 2026 to 2033. North America led the market in 2025, accounting for 52.5% of global revenue.

What Is Driving the AI in Neurology Market?

Several structural changes in neurological healthcare are supporting market expansion:

• Earlier diagnosis: Healthcare providers are increasingly adopting AI to identify neurological abnormalities and support pre-symptomatic or early-stage detection.
• Growing neurological disease burden: Rising prevalence of stroke, Alzheimer's disease, dementia, and other neurological conditions is increasing demand for advanced diagnostic and monitoring technologies.
• Precision medicine: AI can help clinicians analyze large volumes of patient and imaging data to support more individualized treatment decisions.
• Clinical workflow optimization: Automated image interpretation, triage, documentation, and decision-support capabilities can reduce workload and improve operational efficiency.
• Remote monitoring: AI-enabled monitoring technologies are expanding access to neurological care beyond traditional hospital environments.
• Government and regulatory support: Evolving digital-health policies and regulatory pathways are encouraging the development and adoption of AI-enabled medical technologies.

Market Segmentation: Where Is Demand Concentrated?

The market demonstrates strong concentration across applications, neurological conditions, components, and end-use settings.

Neuroimaging & diagnostics represented the largest application category, capturing 36.0% of revenue in 2025. Machine learning and related AI technologies are increasingly being used to analyze complex MRI, CT, and PET images and support faster clinical interpretation.

By neurological condition, stroke accounted for the largest share at 26.8% in 2025. Meanwhile, applications involving Alzheimer's disease and dementia are experiencing rapid growth as healthcare systems seek improved tools for disease detection, assessment, and longitudinal monitoring.

From a technology perspective, software remained the leading component, representing 58.0% of the market in 2025. AI software platforms provide the analytical layer for imaging, diagnosis, monitoring, and clinical decision support, while AI-enabled hardware is also gaining momentum.

Hospitals & clinics represented the leading end-use segment, with a 57.7% share in 2025, reflecting the concentration of neurological diagnosis and treatment within institutional healthcare environments.

Download a free sample report or claim your copy of this full market intelligence report

Technology Innovation Is Reshaping Neurological Care

Innovation remains a defining characteristic of the AI in neurology industry. Machine learning, deep learning, cloud computing, advanced medical imaging, and AI-assisted clinical decision-making are expanding the capabilities of neurological diagnostics and monitoring.

A notable example emerged in June 2025, when Hyperfine received FDA clearance for its 10th-generation AI software, Optive AI, and a next-generation Swoop scanner powered by Optive AI. The development positioned the technology as an FDA-cleared AI-powered portable brain MRI system, demonstrating the industry's movement toward more accessible and AI-enhanced neurological imaging.

AI is also expanding into real-time neurological interfaces. In January 2025, Synchron announced a collaboration with NVIDIA to use the Holoscan AI platform in advancing its Stentrode brain-computer interface technology. The initiative focuses on real-time neural signal processing and AI models designed to support thought-to-device control for patients with ALS and paralysis.

Partnerships and Geographic Expansion

Strategic partnerships are becoming increasingly important as AI companies seek to combine clinical expertise, computing infrastructure, financing, and proprietary technologies. Collaboration can also help vendors expand into new geographic markets and accelerate commercialization.

Geographic expansion is another important characteristic of the industry. Greater international penetration provides companies with access to diverse clinical datasets, new healthcare systems, and broader commercial opportunities.

For example, in February 2026, Brainomix extended its Series C financing to approximately USD 25.4 million (£18.8 million). The financing was led by Parkwalk Advisors alongside new U.S.-based investor Modi Ventures, with the funding intended to support expansion into the U.S. market.

Regulation Remains a Critical Market Factor

Regulatory oversight has a substantial influence on AI adoption in neurology because many AI applications directly affect diagnosis, treatment decisions, and patient monitoring.

In the U.S., the FDA regulates AI/ML-enabled Software as a Medical Device (SaMD), including products that may enter established regulatory pathways such as 510(k). Clinical validation, safety, performance, and lifecycle management remain central considerations.

In Europe, the EU Medical Device Regulation (EU MDR) and EU AI Act introduce additional compliance requirements for applicable high-risk AI systems. Areas such as data quality, cybersecurity, conformity assessment, transparency, and post-market surveillance are becoming increasingly important for developers.

Consequently, regulatory compliance can create barriers to market entry while simultaneously increasing confidence in clinically validated AI solutions.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Market Opportunities and Challenges

Major Growth Opportunities

The strongest opportunities are emerging around:

• AI-assisted early detection of neurological disorders
• Automated neuroimaging analysis
• Stroke diagnosis and treatment workflows
• Alzheimer's disease and dementia assessment
• Remote neurological monitoring
• AI-powered portable imaging
• Precision medicine and personalized treatment
• Real-time neural signal processing
• Cloud-based neurological decision-support platforms

Key Market Challenges

Despite strong growth prospects, market participants face several constraints:

• High implementation and integration costs
• Complex regulatory approval processes
• Requirements for extensive clinical validation
• Data privacy and cybersecurity concerns
• Limited digital-health infrastructure in developing markets
• Interoperability challenges across healthcare IT systems
• Need for high-quality, representative clinical datasets

Key Companies in AI in Neurology

Companies profiled in the AI in neurology market include:

• Cortechs.ai
• Viz.ai
• RapidAI (trademarks of iSchemaView, Inc.)
• Aidoc
• Brainomix
• Avicenna.AI
• Natus
• Hyperfine
• PERSYST DEVELOPMENT LLC

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.